The biotech sector has rebounded from a sharp sell-off earlier this year and could deliver even more value to investors who know where to look.
Insights
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
AI is reshaping industries with applications ranging from cancer detection to surgical training, underscoring the need for active research and responsible engagement.
At JHI's recent Madrid Investment Summit, Ali spoke with Jeremiah Buckley and Luke Newman about where they are finding the most compelling opportunities within equities.
Recent deals within the AI ecosystem seek to align major players in the effort to meet voracious demand.
Why the AI wave’s unique dynamics distinguish it from the dotcom era.
How balanced strategies can help investors stay true to their long-term objectives.
U.S. companies have thus far withstood the Trump administration’s barrage of tariffs, but signs of stress are emerging in the most exposed sectors.
Tech sector volatility can lead to attractive entry points for investors seeking to increase exposure to powerful secular themes.
Perspectives on volatility, tariffs, AI, and U.S. consumer strength.
AI disruption has sparked debate about the future of software companies, but the reality is more nuanced than the prevailing doom-and-gloom narrative suggests.
Optimism is returning to the biotech space, and we see durable drivers behind the recent performance recovery.